Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Grieve, Richard
Guerriero, Carla
Walker, Jemma
Tomlin, Keith
Langham, Julia
Harding, Simon
Chakravathy, Usha
Carpenter, James
and
Reeves, Barnaby C.
2009.
Verteporfin Photodynamic Therapy Cohort Study.
Ophthalmology,
Vol. 116,
Issue. 12,
p.
2471.
Byford, Sarah
Barrett, Barbara
Dubourg, Richard
Francis, Jennifer
and
Sisk, Jane
2010.
Evidence‐Based Decisions and Economics.
p.
43.
Sampat, Bhaven
and
Drummond, Michael
2011.
Another Special Relationship? Interactions between Health Technology Policies and Health Care Systems in the United States and the United Kingdom.
Journal of Health Politics, Policy and Law,
Vol. 36,
Issue. 1,
p.
119.
van de Wetering, Gijs
Woertman, Willem H.
and
Adang, Eddy M.
2012.
Time to incorporate time in cost-effectiveness analysis.
The European Journal of Health Economics,
Vol. 13,
Issue. 3,
p.
223.
McGuire, Alistair
2012.
The European value-pricing game.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 12,
Issue. 1,
p.
5.
Dixon, Anna
and
Poteliakhoff, Emmi
2012.
Back to the future: 10 years of European health reforms.
Health Economics, Policy and Law,
Vol. 7,
Issue. 1,
p.
1.
Silva, Maria Laura
Späth, Hans-Martin
Perrier, Lionel
and
Moumjid, Nora
2012.
The use of economic evaluations in health decision-making at the macro level: a literature review.
Journal de gestion et d'économie médicales,
Vol. Vol. 30,
Issue. 4,
p.
231.
Chambers, James D.
Lord, Joanne
Cohen, Joshua T.
Neumann, Peter J.
and
Buxton, Martin J.
2013.
Illustrating Potential Efficiency Gains from Using Cost-Effectiveness Evidence to Reallocate Medicare Expenditures.
Value in Health,
Vol. 16,
Issue. 4,
p.
629.
Silva, Maria Laura
Späth, Hans-Martin
Perrier, Lionel
and
Moumjid, Nora
2013.
The use of economic evaluations in health decision-making at the macro level: a literature review.
Journal de gestion et d'économie médicales,
Vol. Vol. 31,
Issue. 1,
p.
31.
Chambers, James D.
2014.
Do Changes in Drug Coverage Policy Point to an Increased Role for Cost-Effectiveness Analysis in the USA?.
PharmacoEconomics,
Vol. 32,
Issue. 8,
p.
729.
Bryan, Stirling
and
Gold, Marthe
2015.
Comparative Effectiveness Research in Health Services.
p.
1.
Gusmano, Michael K.
2015.
Objections to the use of cost-effectiveness analysis in the US: reflecting on ‘Has the time come for cost-effectiveness analysis in US health care?’.
Health Economics, Policy and Law,
Vol. 10,
Issue. 4,
p.
419.
Miller, Jeffrey D.
Lenhart, Gregory M.
Bonafede, Machaon M.
Lukes, Andrea S.
and
Laughlin-Tommaso, Shannon K.
2015.
Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives.
Population Health Management,
Vol. 18,
Issue. 5,
p.
373.
Luyten, Jeroen
and
Beutels, Philippe
2016.
The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness.
Health Affairs,
Vol. 35,
Issue. 2,
p.
212.
Bryan, Stirling
and
Gold, Marthe
2016.
Comparative Effectiveness Research in Health Services.
p.
205.
Britt, Rachel B.
Hashem, Mohamed G.
Bryan, William E.
Kothapalli, Radhika
and
Brown, Jamie N.
2016.
Economic Outcomes Associated with a Pharmacist-Adjudicated Formulary Consult Service in a Veterans Affairs Medical Center.
Journal of Managed Care & Specialty Pharmacy,
Vol. 22,
Issue. 9,
p.
1056.
Britt, Rachel B.
Hashem, Mohamed G.
Bryan, William E.
Kothapalli, Radhika
and
Brown, Jamie N.
2016.
Economic Outcomes Associated with a Pharmacist-Adjudicated Formulary Consult Service in a Veterans Affairs Medical Center.
Journal of Managed Care & Specialty Pharmacy,
Vol. 22,
Issue. 9,
p.
1051.
Li, Nanxin
Yang, Xi
Fan, Liangyi
Totev, Todor
Guerin, Annie
Chen, Lei
Bhattacharyya, Subrata
and
Joseph, George
2017.
Nilotinib versus dasatinib as second-line therapy in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase who are resistant or intolerant to imatinib: a cost-effectiveness analysis based on real-world data.
Journal of Medical Economics,
Vol. 20,
Issue. 4,
p.
328.
Goto, Daisuke
Shih, Ya-Chen Tina
Lecomte, Pascal
Olson, Melvin
Udeze, Chukwukadibia
Park, Yujin
and
Mullins, C. Daniel
2017.
Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis.
PharmacoEconomics,
Vol. 35,
Issue. 7,
p.
685.
Chapman, Richard H.
and
Kumar, Varun
2019.
Can We Develop Sustainable and Sharable Cost-Effectiveness Models for Value Assessment in the U.S. Health Care System?.
Journal of Managed Care & Specialty Pharmacy,
Vol. 25,
Issue. 5,
p.
521.